m+Medelevator.RU
← Поиск публикаций
Journal of thrombosis and haemostasis : JTH · 2025

Endothelial NADPH oxidase 5 overexpression promotes thrombosis and alters thrombus composition by sex-dependent mechanisms in mice.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Marqués Javier, Fernández-Irigoyen Joaquín, Martínez-Azcona María, Ainzúa Elena, Marqués Victor, Roncal Carmen, Orbe Josune, Santamaría Enrique, Zalba Guillermo

Аннотация

BACKGROUND: Different members of the NADPH oxidases family (NOXs) participate in thrombosis. Nevertheless, the information about NOX5 in this process is scarce.

OBJECTIVES: The aim of this study was to test whether chronic expression of NOX5 may modulate thrombosis.

METHODS: To test this hypothesis, mice expressing human NOX5 at the endothelium and their control littermates underwent a FeCl3-induced thrombosis model in the carotid artery. The composition of the thrombi obtained from these mice was analyzed by proteomics. The derived findings were corroborated by molecular analysis in vivo, in vitro, and ex vivo. Finally, the antithrombic effects of N-acetylcysteine and the pan-NOX inhibitor ML090 were tested.

RESULTS: The results from this assay indicate that endothelial NOX5 expression promotes thrombosis in vivo in a sex-dependent manner. In female mice, NOX5 enhances prostaglandin E2 secretion and alters the expression of endothelial adhesion molecules. In male mice, NOX5 partially promotes the activation of circulating neutrophils. Both, N-acetylcysteine and ML090 protect against thrombosis in vivo.

CONCLUSION: In conclusion, our findings demonstrate that endothelial NOX5 plays a role in thrombosis, indicating that this oxidase should be considered as a therapeutic target to prevent thrombosis.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты